IL-5 – What diseases have high levels of IL-5? How are the treated? Do you know when trials of IL-5 will take place? Will EGPA patients be eligible to participate?

IL-5 – What diseases have high levels of IL-5? How are the treated? Do you know when trials of IL-5 will take place? Will EGPA patients be eligible to participate?

December 1, 2012

Mepolizumab is an IL-5-blocking antibody and there is enthusiasm for studying it in EGPA/Churg-Strauss. Trials have been proposed, but I do not whether and when they will start.

(Click the back button in your browser to go back to the FAQ page.)

Vasculitis Foundation About

The Vasculitis Foundation is the international organization for patients with vasculitis, their families, friends and the health care professionals who care for them.

Connect with us on social media!

Start Doing Your Bit to Help Others. Support Our Work.

Chip in with your donation

Our Mission

Building upon the collective strength of the vasculitis community, the Foundation supports, inspires and empowers individuals with vasculitis and their families through a wide range of education, research, clinical, and awareness initiatives.

The Vasculitis Foundation is a registered 501 (c) (3) non-profit organization. All contributions are 100% tax-deductible.

Contact Us

Click here to send us an email!
Mail:
Vasculitis Foundation
PO Box 28660
Kansas City, MO 64188
1.816.436.8211 or 1.800.277.9474

Participate in Research

Learn how you can participate in clinical trials - National Institutes of Health

All Rights Reserved